Supplements of red wine antioxidant don't help obese men

November 28, 2012 by Denise Mann, Healthday Reporter
Supplements of red wine antioxidant don't help obese men
Study should put claims of health benefits to rest, experts say.

(HealthDay)—Despite showing early promise in some animal studies, supplements of resveratrol, an antioxidant found aplenty in red wine, did not improve insulin sensitivity or heart health in obese men, a small trial found.

Researchers found no difference in insulin sensitivity—the measure of how well the body uses the —in 24 obese but otherwise healthy men who took daily 1,500-milligram doses of resveratrol compared to other men who took an inactive placebo for four weeks.

Nor were there any changes in other signs of , including blood pressure, levels of called triglycerides and other fats.

The study, led by Dr. Morten Poulsen at Aarhus University Hospital in Denmark, appears online Nov. 28 in the journal Diabetes.

Dr. Vivian Fonseca, president of medicine and science for the , said he is not surprised that the study did not show any benefits associated with the resveratrol supplements.

"People who drink red wine and do so in moderation may have that may allow them to live longer and decrease their , but putting it into a pill doesn't solve the problem for people who live unhealthy lives, like the men in the study," Fonseca said. "I think some of the initial animal studies on resveratrol were hyped far more than they should have been and this study should put all of that to rest."

Dr. John Buse, a professor of medicine at the University of North Carolina at Chapel Hill, agreed. "It is nice to see the lack of efficacy so elegantly demonstrated," he said. "There cannot be much question remaining at this point."

People at risk for diabetes can take , he noted. "The most important thing is to be screened for diabetes if you are at risk," Buse said. This includes everyone older than 45 and younger people who are overweight.

"To reduce the risk of diabetes, reduce calorie intake with an aim to reduce weight by 5 to 10 percent and increase physical activity to at least 30 minutes at least five days a week," Buse advised. "That reduces diabetes risk by about 60 percent over three years."

For her part, Dr. Tara Narula, associate director of cardiac care at Lenox Hill Hospital in New York City, said, "People are always looking for a one-stop, easy cure-all supplement or quick fix, but the things that work require work."

While these supplements may not stack up, moderate alcohol consumption may have some health benefit, Narula said. "If you are going to drink, red wine is the one that I recommend because there is a potential benefit from compounds in the wine itself," she added.

That's good advice, said Dr. Howard Weintraub, a cardiologist at NYU Langone Medical Center. "There are benefits within the wine that extend beyond the resveratrol, and part of it may be because alcohol helps improve good cholesterol," he said. "If you enjoy , a glass or two a day may be beneficial." But, he cautioned, just because a glass or two can be good for you doesn't mean that more is better.

Explore further: Resveratrol falls short in health benefits

More information: Concerned about your risk for diabetes? Get the facts on prevention at the American Diabetes Association.

Related Stories

Resveratrol falls short in health benefits

October 25, 2012
Resveratrol, an ingredient in red wine thought to improve insulin sensitivity, reduce risk of heart disease and increase longevity, does not appear to offer these benefits in healthy women, new research at Washington University ...

Does moderate wine consumption improve lung function?

March 8, 2012
A research team from the Netherlands assessed the impact of wine and resveratrol (a natural polyphenol found in high quantities in red wine) on lung function. It also looked at genetic factors and mechanisms by which resveratrol ...

First clinical trial of red wine ingredient shows metabolic shifts

November 1, 2011
When obese men take a relatively small dose of resveratrol in purified form every day for a month, their metabolisms change for the better. In fact, the effects appear to be as good for us as severe calorie restriction. Resveratrol ...

Non-alcoholic red wine may help reduce high blood pressure

September 6, 2012
Men with high risk for heart disease had lower blood pressure after drinking non-alcoholic red wine every day for four weeks, according to a new study in the American Heart Association journal Circulation Research.

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.